Extramedullary intracranial localization of multiple myeloma and treatment with novel agents: A retrospective survey of 50 patients

Cancer

Volumn 118, Issue 6, 2012, Pages 1574-1584

  Gozzetti, Alessandro ^a   Cerase, Alfonso ^a   Lotti, Flavia ^b   Rossi, Davide ^c   Palumbo, Antonio ^d,n   Petrucci, Maria Teresa ^e   Patriarca, Francesca ^f   Nozzoli, Chiara ^g   Cavo, Michele ^h   Offidani, Massimo ⁱ   Floridia, Michele ^j   Berretta, Salvatore ^k   Vallone, Roberto ^l   Musto, Pellegrino ^m   Lauria, Francesco ^a  

^a UNIVERSITY HOSPITAL OF SIENA   (Italy)

^b Division of Hematology   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

^f UNIVERSITY OF UDINE   (Italy)

^g CAREGGI UNIVERSITY HOSPITAL   (Italy)

^h UNIVERSITY OF BOLOGNA   (Italy)

ⁱ Clinica di Ematologia   (Italy)

^j AO Ferrarotto   (Italy)

^k Cattedra di Ematologia   (Italy)

^l DH Ematologico G Rummo Benevento   (Italy)

^m REFERRAL CANCER CENTER OF BASILICATA   (Italy)

ⁿ MOLINETTE HOSPITAL   (Italy)

more..

Author keywords

bortezomib; central nervous system; head; intracranial; lenalidomide; multiple myeloma; thalidomide

Indexed keywords

BETA 2 MICROGLOBULIN; BORTEZOMIB; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LENALIDOMIDE; MELPHALAN; METHOTREXATE; PREDNISOLONE; PREDNISONE; TEMOZOLOMIDE; THALIDOMIDE; TOPOTECAN; VINCRISTINE;

ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM MYELOMATOSIS; CEREBROSPINAL FLUID; CHROMOSOME 13Q; CHROMOSOME ANALYSIS; CHROMOSOME DELETION 13; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; MULTIPLE MYELOMA; NEUROIMAGING; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEO DURAL MULTIPLE MYELOMA; OSTEO DURAL MYELOMA; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES;

EID: 84857996397     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26447     Document Type: Article

References (37)

1. Cerase A, Tarantino A, Gozzetti A, et al. Intracranial involvement in plasmacytomas and multiple myeloma: a pictorial essay. Neuroradiology. 2008; 50: 665-674.
2. Nieuwenhuizen L, Biesma DH,. Central nervous system myelomatosis: review of the literature. Eur J Haematol. 2008; 80: 1-9. (Pubitemid 350265222)
3. Patriarca F, Zaja F, Silvestri F, et al. Meningeal and cerebral involvement in multiple myeloma patients. Ann Hematol. 2001; 80: 758-762. (Pubitemid 34041436)
4. Moran CC, Anderson CC, Caldemeyer KS, Smith RR,. Meningeal myelomatosis: CT and MR appearances. AJNR Am J Neuroradiol. 1995; 16: 1501-1503.
5. Turhal M, Henehan D, Kaplan KL,. Multiple myeloma: a patient with unusual features including intracranial and meningeal involvement, testicular involvement, organomegaly, and plasma cell leukemia. Am J Hematol. 1998; 57: 51-56. (Pubitemid 28047199)
6. Schluterman KO, Athanasios B, Fassas T, et al. Multiple myeloma invasion of the central nervous system. Arch Neurol. 2004; 61: 1423-1429. (Pubitemid 39202226)
7. Leifer D, Grabowski T, Simonian N, Demirjian ZN,. Leptomeningeal myelomatosis presenting with mental status changes and other neurologic findings. Cancer. 1992; 70: 99-104.
8. Ackroyd S, Swirsky D, Kay CL, Parapia LA,. A case of myelomatous meningitis. Br J Haematol. 2004; 126: 627. (Pubitemid 39221295)
9. Lupu VD, Saini N, Balish M,. CNS myelomatosis. Neurology. 2005; 22: 64.
10. Nagai K, Ohnaka T, Okuno T, et al. Meningeal involvement in multiple myeloma. Acta Haematol. 1981; 66: 39-43. (Pubitemid 11034113)
11. Gomez GA, Krishnamsetty RM,. Successful treatment of meningeal myeloma with combination of radiation therapy, chemotherapy, and intrathecal therapy. Arch Intern Med. 1986; 146: 194-196. (Pubitemid 16158652)
12. Truong LD, Kim HS, Estrada R,. Meningeal myeloma. Am J Clin Pathol. 1982; 78: 532-535. (Pubitemid 12003572)
13. Oda K, Egawa H, Okuhara T, et al. Meningeal involvement in Bence Jones multiple myeloma. Cancer. 1991; 67: 1900-1902.
14. Escorsell A, Lopez-Guillermo A, Blade J, et al. Meningeal infiltration in multiple myeloma. Analysis of a new case and literature review. Rev Clin Esp. 1992; 191: 478-480. (Pubitemid 23036056)
15. Fassas AB, Muwalla F, Berryman T, et al. Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extra-medullary manifestations. Br J Haematol. 2002; 117: 103-108. (Pubitemid 34304427)
16. Raab MS, Podar K, Breitkreutz I, et al. Multiple myeloma. Lancet. 2009; 374: 324-339.
17. Kumar SK, Rajkumar SV, Dispenzieri A, et al. Improved survival in multiple myeloma and the impact of novel therapies. Blood. 2008; 111: 2516-2520.
18. Hattori Y, Iguchi T,. Thalidomide for the treatment of multiple myeloma. Congenit Anom. 2004; 44: 125-136.
19. Gozzetti A, Cerase A, Tarantino A, et al. Multiple myeloma involving the cavernous sinus: a report of 3 cases and response to bortezomib. Clin Lymphoma Myeloma. 2007; 7: 376-378. (Pubitemid 46725241)
20. Patriarca F, Prosdocimo S, Tomadini V, et al. Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation. Haematologica. 2005; 90: 278-279. (Pubitemid 40293302)
21. Greip PR, San Miguel JF, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol. 2005; 23: 3412-3420.
22. Durie BG, Salmon SE,. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer. 1975; 36: 842-844.
23. Pirrotta MT, Gozzetti A, Cerase A, et al. Unusual discordant responses in two multiple myeloma patients during bortezomib treatment. Onkologie. 2008; 31: 45-47. (Pubitemid 351252940)
24. Roddie P, Collie D, Johnson P,. Myelomatous involvement of the dura mater: a rare complication of multiple myeloma. J Clin Pathol. 2000; 53: 398-399. (Pubitemid 30256911)
25. Durie BG, Harousseau JL, Miguel JS, et al. International Myeloma Working Group International uniform response criteria for multiple myeloma. Leukemia. 2006; 20: 1467-1473. (Pubitemid 44264086)
26. Petersen S, Wagner A, Gimsing P,. Cerebral and meningeal multiple myeloma after autologous stem cell transplantation. A case report and review of the literature. Am J Hematol. 1999; 62: 228-233.
27. Cornford EM, Young D, Paxton JW, et al. Melphalan penetration of the blood-brain barrier via the neutral amino acid transporter in tumor-bearing brain. Cancer Res. 1992; 52: 138-143.
28. Greig NH, Momma S, Sweeney DJ, et al. Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system. Cancer Res. 1987; 15: 1571-1576. (Pubitemid 17044485)
29. Quach H, Ryan G, Ganju V, Prince HM,. Effective treatment of leptomeningeal multiple myeloma with total craniospinal irradiation supported by second allogeneic donor stem cell infusion. Bone Marrow Transplant. 2005; 35: 423-424. (Pubitemid 40309492)
30. Brenner B, Nagler A, Viener A, et al. Partial response of meningeal myeloma to craniospinal radiotherapy. Scand J Haematol. 1986; 37: 360-362. (Pubitemid 17211307)
31. Chang H, Sloan S, Li D, Stewart K,. Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletions. Br J Haematol. 2004; 127: 280-284. (Pubitemid 39468940)
32. Bergsagel PL, Kuehl WM,. Chromosome translocations in multiple myeloma. Oncogene. 2001; 20: 5611-5622.
33. Vicari P, Ribas C, Sampaio M, et al. Can thalidomide be effective to treat plasma cell leptomeningeal infiltration? Eur J Haematol. 2003; 70: 198-199. (Pubitemid 36606084)
34. Yutaka H, Mariko Y, Shinichiro O, et al. Thalidomide for the treatment of leptomeningeal multiple myeloma. Eur J Haematol. 2006; 76: 358-359.
35. Schwartz R, Davidson T,. Pharmacology, pharmacokinetics and practical applications of bortezomib. Oncology. 2004; 18: 14-21.
36. de Groot J, Milano V,. Improving the prognosis for patients with glioblastoma: the rationale for targeting Src. J Neurooncol. 2009; 95: 151-163.
37. Phuphanich S, Supko JG, Carson KA, et al. Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma. J Neurooncol. 2010; 100: 95-103.